AIDX
20/20 Biolabs updates investors on OneTest filing
The company released an investor presentation navigating revenue projections and expected FDA authorization timelines for its OneTest product.
AIDX news
Latest 5 stories · newest Sep 2, 2026
AIDX
20/20 Biolabs Publishes Investor Presentation for August Webinar
The company released an investor presentation outlining its strategic initiatives and risks for upcoming regulatory approvals and financial projections. Market relevance: Focus on regulatory progress and market strategy.
AIDX
20/20 Biolabs Publishes Investor Presentation with Revenue Projections
The company released a July 2026 presentation detailing financial models and clinical data for the OneTest platform. Market relevance hinges on potential FDA authorization and CMS reimbursement rates.
AIDX
AIDX
20/20 BioLabs reports Q1 2026 revenue of $0.4M; expects growth from state firefighter programs
20/20 BioLabs reported Q1 2026 revenue of $0.4 million and raised $5.0 million in private placement, with cash position of $4.2 million as of March 31, 2026. The company expects meaningful revenue growth in Q2 2026 from Maryland's state-funded firefighter cancer screening program and recently secure…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same AIDX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/AIDX/newsSTART FREE